Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CPRI | IE |
|---|---|---|
| Price | $14.49 | $10.33 |
| Change today | ▲ 0.35% | ▼ 1.05% |
| Market cap | $1.65B | $1.65B |
| Return, 3 months | -25.4% | +13.0% |
| Return, year to date | -40.6% | -35.4% |
| Return, 1 year | -31.6% | -15.3% |
| P/E (TTM) | 11.1 | -7.8 |
| P/B | 11.9 | 3.1 |
| P/E percentile vs own 5y | 65th | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +39.3% | +83.9% |
| Analyst buy share | 45% | 100% |
| RSI (14) | 50 | 51 |
| 30-day volatility | 46.8% | 73.5% |
| Max drawdown, 1 year | -54.0% | -59.4% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
